# Endocannabinoid System &#038; PTSD: Cannabis in Dual Diagnosis

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cannabis-use-trauma-focused-treatment-ptsd/
> **Published:** 2026-03-03T00:04:15-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T12:01:23-04:00
> **Clinical Summary:** Explore cannabis use and trauma-focused treatment outcomes in PTSD and co-occurring substance use disorders for optimized clinical care.

---

#### Clinical Takeaway

People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments, and [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) does not appear to undermine treatment outcomes compared to non-cannabis users. Clinicians should not withhold or delay evidence-based trauma-focused care for patients simply because they are using cannabis.

### #6 Cannabis use and trauma-focused treatment for co-occurring posttraumatic stress disorder and substance use disorders: A meta-analysis of individual patient data.

**Citation:** Hill Melanie L et al. *[Cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and trauma-focused treatment for co-occurring posttraumatic stress disorder and substance use disorders: A meta-analysis of individual patient data.* Journal of [anxiety disorders](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/). 2024. PMID: 38266511.

**Study type:** Meta-Analysis, Journal Article, Research Support, N.I.H., Extramural  | 
 **Topic area:** Anxiety & PTSD  | 
 **CED Score:** 12

Design: 6 Journal: 0 N: 4 Recency: 1 Pop: 2 Human: 1 Risk: -2

 Why This Matters
 This meta-analysis clarifies whether cannabis use compromises the efficacy of evidence-based trauma-focused treatments in patients with co-occurring PTSD and substance use disorders, a clinically prevalent population where treatment guidance is limited. The findings directly inform clinical decision-making regarding patient selection and treatment planning for trauma-focused interventions in individuals with active cannabis use. Understanding these treatment outcomes is essential for optimizing therapeutic strategies and setting appropriate expectations in a patient population with substantial psychiatric comorbidity and elevated relapse risk.

**Quality Gate Alerts:**

- Preclinical only

**Abstract:** High rates of cannabis use among people with posttraumatic stress disorder (PTSD) have raised questions about the efficacy of evidence-based PTSD treatments for individuals reporting cannabis use, particularly those with co-occurring alcohol or other substance use disorders (SUDs). Using a subset of four randomized [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) (RCTs) included in Project Harmony, an individual patient meta-analysis of 36 RCTs (total N = 4046) of treatments for co-occurring PTSD+SUD, we examined differences in trauma-focused (TF) and non-trauma-focused (non-TF) treatment outcomes for individuals who did and did not endorse baseline cannabis use (N = 410; 70% male; 33.2% endorsed cannabis use). Propensity score-weighted mixed effects modeling evaluated main and interactive effects of treatment assignment (TF versus non-TF) and baseline cannabis use (yes/no) on attendance rates and within-treatment changes in PTSD, alcohol, and non-cannabis drug use severity. Results revealed significant improvements across outcomes among participants in all conditions, with larger PTSD symptom reductions but lower attendance among individuals receiving TF versus non-TF treatment in both cannabis groups. Participants achieved similar reductions in alcohol and drug use across all conditions. TF outperformed non-TF treatments regardless of recent cannabis use, underscoring the importance of reducing barriers to accessing TF treatments for individuals reporting cannabis use.

 Clinical Perspective

This meta-analysis of individual patient data from Project Harmony offers valuable reassurance that trauma-focused treatments for PTSD remain efficacious even among patients with concurrent cannabis use and other substance use disorders, addressing a clinically relevant question about treatment generalizability. However, several important caveats warrant consideration: the analysis draws from only four RCTs within the larger dataset, cannabis use was likely measured as a binary variable rather than quantifying frequency or potency (which vary substantially in modern markets), and the trials themselves may have enrolled relatively motivated or treatment-engaged populations not fully representative of real-world complexity. The findings do not address whether cannabis use itself impedes PTSD recovery or whether active [cannabis dependence](https://cedclinic.com/ptsd-cannabis-dependence-veterans-social-support/) requires concurrent intervention alongside trauma-focused therapy. For clinical practice, this work supports proceeding with evidence-based trauma-focused treatments in patients with comorbid cannabis and other substance use without presumptively withholding care, while maintaining realistic expectations that ongoing or heavy cannabis use may complicate treatment engagement and outcomes, and individualizing decisions

 |   | 

Further Reading
CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/)
Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/)
CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/)

[View on PubMed ↗](https://pubmed.ncbi.nlm.nih.gov/38266511/)[Full Text ↗](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11138203/)[DOI ↗](https://doi.org/10.1016/j.janxdis.2024.102827)

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Endocannabinoid System Clinical Research: PTSD and SUD](https://cedclinic.com/cannabis-use-trauma-ptsd-sud-research/)

Explore [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) on the endocannabinoid system's role in PTSD and substance use disorders, highlighting treatment implications.

[Read More](https://cedclinic.com/cannabis-use-trauma-ptsd-sud-research/)

[Cannabis in PTSD Treatment: Meta-Analysis of Trauma-Focused Care](https://cedclinic.com/cannabis-use-ptsd-treatment-outcomes-meta-analysis/)

Review a meta-analysis evaluating cannabis use impact on trauma-focused PTSD treatments and patient outcomes.

[Explore Study](https://cedclinic.com/cannabis-use-ptsd-treatment-outcomes-meta-analysis/)

[Cannabinoid Clinical Trials: PTSD and Substance Use Disorder](https://cedclinic.com/cannabis-use-trauma-focused-treatment-ptsd-sud-outcomes/)

Discover [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) investigating cannabinoids in the treatment of PTSD and co-occurring substance use disorders.

[Learn More](https://cedclinic.com/cannabis-use-trauma-focused-treatment-ptsd-sud-outcomes/)

Have thoughts on this? Share it:

[X Share on X](https://twitter.com/intent/tweet?text=Endocannabinoid%20System%20%26%20PTSD%3A%20Cannabis%20in%20Dual%20Diagnosis&url=https%3A%2F%2Fcedclinic.com%2Fcannabis-use-trauma-focused-treatment-ptsd%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabis-use-trauma-focused-treatment-ptsd%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Endocannabinoid%20System%20%26%20PTSD%3A%20Cannabis%20in%20Dual%20Diagnosis%20https%3A%2F%2Fcedclinic.com%2Fcannabis-use-trauma-focused-treatment-ptsd%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
